Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Has FDA moved the goalposts?

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Mar 30, 2023 9:03am

253 Views

Post# 35368745

RE:RE:RE:RE:RE:Has FDA moved the goalposts?

Good post again Steven. It's easy to turn negatively every move or possible move by the FDA. The results so far are good enough for BTD shortly followed by the AA with more results to come. I keep my focus on this and wait for good NR to add some shares! GL

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project